These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36606147)

  • 1. Nanoantibodies: small molecules, big possibilities.
    Pedreáñez A; Mosquera-Sulbarán J; Muñóz N; Tene D; Robalino J
    BioTechnologia (Pozn); 2021; 102(3):321-336. PubMed ID: 36606147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single domain antibody: Development and application in biotechnology and biopharma.
    Yu T; Zheng F; He W; Muyldermans S; Wen Y
    Immunol Rev; 2024 Aug; ():. PubMed ID: 39166870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanobodies: From Serendipitous Discovery of Heavy Chain-Only Antibodies in Camelids to a Wide Range of Useful Applications.
    Ji F; Ren J; Vincke C; Jia L; Muyldermans S
    Methods Mol Biol; 2022; 2446():3-17. PubMed ID: 35157266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanobodies: natural single-domain antibodies.
    Muyldermans S
    Annu Rev Biochem; 2013; 82():775-97. PubMed ID: 23495938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single Domain Antibody application in bacterial infection diagnosis and neutralization.
    Qin Q; Liu H; He W; Guo Y; Zhang J; She J; Zheng F; Zhang S; Muyldermans S; Wen Y
    Front Immunol; 2022; 13():1014377. PubMed ID: 36248787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Camelid immunoglobulins and nanobody technology.
    Muyldermans S; Baral TN; Retamozzo VC; De Baetselier P; De Genst E; Kinne J; Leonhardt H; Magez S; Nguyen VK; Revets H; Rothbauer U; Stijlemans B; Tillib S; Wernery U; Wyns L; Hassanzadeh-Ghassabeh G; Saerens D
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):178-83. PubMed ID: 19026455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single domain camel antibodies: current status.
    Muyldermans S
    J Biotechnol; 2001 Jun; 74(4):277-302. PubMed ID: 11526908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A megadiverse naïve library derived from numerous camelids for efficient and rapid development of VHH antibodies.
    Wang M; Wei L; Xiang H; Ren B; Liu X; Jiang L; Yang N; Shi J
    Anal Biochem; 2022 Nov; 657():114871. PubMed ID: 36108795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and characterization of anti-(mucin MUC1) single-domain antibody in tobacco (Nicotiana tabacum cultivar Xanthi).
    Ismaili A; Jalali-Javaran M; Rasaee MJ; Rahbarizadeh F; Forouzandeh-Moghadam M; Memari HR
    Biotechnol Appl Biochem; 2007 May; 47(Pt 1):11-9. PubMed ID: 17073735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence and evolution of functional heavy-chain antibodies in Camelidae.
    Conrath KE; Wernery U; Muyldermans S; Nguyen VK
    Dev Comp Immunol; 2003 Feb; 27(2):87-103. PubMed ID: 12543123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of nanobodies in plant science and biotechnology.
    Wang W; Yuan J; Jiang C
    Plant Mol Biol; 2021 Jan; 105(1-2):43-53. PubMed ID: 33037986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and optimization of camelid single-domain antibodies: Dirk Saerens' work on nanobodies.
    Saerens D
    World J Biol Chem; 2010 Jul; 1(7):235-8. PubMed ID: 21537479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.
    Wesolowski J; Alzogaray V; Reyelt J; Unger M; Juarez K; Urrutia M; Cauerhff A; Danquah W; Rissiek B; Scheuplein F; Schwarz N; Adriouch S; Boyer O; Seman M; Licea A; Serreze DV; Goldbaum FA; Haag F; Koch-Nolte F
    Med Microbiol Immunol; 2009 Aug; 198(3):157-74. PubMed ID: 19529959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs).
    Maass DR; Sepulveda J; Pernthaner A; Shoemaker CB
    J Immunol Methods; 2007 Jul; 324(1-2):13-25. PubMed ID: 17568607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of Antigen-Specific VHH Single-Domain Antibodies by Combining Animal Immunization with Yeast Surface Display.
    Roth L; Krah S; Klemm J; Günther R; Toleikis L; Busch M; Becker S; Zielonka S
    Methods Mol Biol; 2020; 2070():173-189. PubMed ID: 31625096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunobiological role of llama heavy-chain antibodies against a bacterial beta-lactamase.
    Ferrari A; Rodríguez MM; Power P; Weill FS; De Simone EA; Gutkind G; Leoni J
    Vet Immunol Immunopathol; 2007 Jun; 117(3-4):173-82. PubMed ID: 17448545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanobody-based heavy chain antibodies and chimeric antibodies.
    Koch-Nolte F
    Immunol Rev; 2024 Aug; ():. PubMed ID: 39212236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Middle East respiratory syndrome coronavirus specific antibodies in naturally exposed Israeli llamas, alpacas and camels.
    David D; Rotenberg D; Khinich E; Erster O; Bardenstein S; van Straten M; Okba NMA; Raj SV; Haagmans BL; Miculitzki M; Davidson I
    One Health; 2018 Jun; 5():65-68. PubMed ID: 29911167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction to heavy chain antibodies and derived Nanobodies.
    Vincke C; Muyldermans S
    Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique single-domain antigen binding fragments derived from naturally occurring camel heavy-chain antibodies.
    Muyldermans S; Lauwereys M
    J Mol Recognit; 1999; 12(2):131-40. PubMed ID: 10398404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.